Vendor source

Reviewed 10 Jul 2026

Completeness Comprehensive (83%)

Rho is a screening tool that analyzes frontal radiographs of the lumbar spine, thoracic spine, chest, pelvis, knee, or hand performed for any clinical indication in patients aged 50 years and older. The algorithm was developed using machine learning to generate a risk score that correlates with a patient's likelihood of having low bone mineral density.

Supported by 5 papers

Key features

Automatic

Opportunistic

Risk score

General Information

Product name

Rho

Company

Modality

X-ray

Main task

Classification

Subspeciality

MSK

Disease targeted

Osteoporosis, low bone mass

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

De novo 510(k) cleared

Class:

Class II

FDA Number:

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Adult, Elderly

Input

Age, sex, frontal radiograph

Input format

DICOM

Output

A risk score that correlates with the patient's likelihood of having low BMD

Output format

DICOM-PDF, PNG

Integration

Integration in standard reading environment (PACS)

Deployment

Locally on dedicated hardware, Locally virtualized (virtual machine, docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

1 - 10 minutes

Population

Patient aged 50 years and over, undergoing X-ray

Market Presence

On market since

05-2026

AI Platforms

Resellers

Not specified

Countries present

3

Paying clinical customers

17

Research/test users

4

Pricing Information

Pricing model

Subscription

Based on

Number of analyses

Source: Vendor | First published: Jul 10, 2026 | Last updated: Jul 10, 2026

Rho - 16 Bit